These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20063406)

  • 1. Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.
    Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
    Mov Disord; 2010 Mar; 25(4):489-93. PubMed ID: 20063406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
    El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D
    FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
    Foulds PG; Mitchell JD; Parker A; Turner R; Green G; Diggle P; Hasegawa M; Taylor M; Mann D; Allsop D
    FASEB J; 2011 Dec; 25(12):4127-37. PubMed ID: 21865317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.
    Li QX; Mok SS; Laughton KM; McLean CA; Cappai R; Masters CL; Culvenor JG; Horne MK
    Exp Neurol; 2007 Apr; 204(2):583-8. PubMed ID: 17258710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress and aminopeptidases in Parkinson's disease patients with and without treatment.
    Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
    Neurodegener Dis; 2011; 8(3):109-16. PubMed ID: 20714110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease.
    Prigione A; Piazza F; Brighina L; Begni B; Galbussera A; Difrancesco JC; Andreoni S; Piolti R; Ferrarese C
    Neurosci Lett; 2010 Jun; 477(1):6-10. PubMed ID: 20399833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.
    Muhlack S; Woitalla D; Welnic J; Twiehaus S; Przuntek H; Müller T
    Neurosci Lett; 2004 Jun; 363(3):284-7. PubMed ID: 15182961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy.
    Todorović Z; Dzoljić E; Novaković I; Mirković D; Stojanović R; Nesić Z; Krajinović M; Prostran M; Kostić V
    J Neurol Sci; 2006 Oct; 248(1-2):56-61. PubMed ID: 16774768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease.
    Gangemi S; Basile G; Merendino RA; Epifanio A; Di Pasquale G; Ferlazzo B; Nicita-Mauro V; Morgante L
    Mediators Inflamm; 2003 Aug; 12(4):251-3. PubMed ID: 14514477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease.
    Tokuda T; Salem SA; Allsop D; Mizuno T; Nakagawa M; Qureshi MM; Locascio JJ; Schlossmacher MG; El-Agnaf OM
    Biochem Biophys Res Commun; 2006 Oct; 349(1):162-6. PubMed ID: 16930553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients.
    Yuan RY; Sheu JJ; Yu JM; Hu CJ; Tseng IJ; Ho CS; Yeh CY; Hung YL; Chiang TR
    J Neurol Sci; 2009 Dec; 287(1-2):64-8. PubMed ID: 19786283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.
    Besong-Agbo D; Wolf E; Jessen F; Oechsner M; Hametner E; Poewe W; Reindl M; Oertel WH; Noelker C; Bacher M; Dodel R
    Neurology; 2013 Jan; 80(2):169-75. PubMed ID: 23255825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low plasma uric acid level in Parkinson's disease.
    Annanmaki T; Muuronen A; Murros K
    Mov Disord; 2007 Jun; 22(8):1133-7. PubMed ID: 17443703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pragmatic approach to biochemical systems theory applied to an alpha-synuclein-based model of Parkinson's disease.
    Sass MB; Lorenz AN; Green RL; Coleman RA
    J Neurosci Methods; 2009 Apr; 178(2):366-77. PubMed ID: 19136028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine elevation in levodopa-treated patients with Parkinson's disease.
    Müller T; Kuhn W
    Mov Disord; 2009 Apr; 24(6):929-32. PubMed ID: 19243072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.